English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Vestaron raised more funding for biopesticide developmentqrcode

May. 15, 2012

Favorites Print
Forward
May. 15, 2012

Vestaron Corporation is pleased to announce that it has completed a Series B Preferred Stock financing, totaling approximately $10.2 million, with participation by major new investors and existing investors.

Proceeds from the Series B financing are being used for continued commercial development of Vestaron's biopesticide peptide based product, accelerated research for synthetic mimics to these peptides, and expanded agricultural biotechnology research and development of the use of Vestaron's peptide as a Bt replacement in GMO portfolios.

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox